These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
76 related articles for article (PubMed ID: 15775564)
1. [Drug therapy for osteoporosis associated with reumatoid arthritis (bisphosphonates)]. Hosoi T Clin Calcium; 2001 May; 11(5):619-22. PubMed ID: 15775564 [TBL] [Abstract][Full Text] [Related]
2. [Pathophysiology, diagnosis and treatment of osteoporosis]. Tsurukami H Clin Calcium; 2003 Jun; 13(6):722-7. PubMed ID: 15775142 [TBL] [Abstract][Full Text] [Related]
3. Advanced glycation end-products (AGEs): a novel therapeutic target for osteoporosis in patients with rheumatoid arthritis. Ji JD; Woo JH; Choi SJ; Lee YH; Song GG Med Hypotheses; 2009 Aug; 73(2):201-2. PubMed ID: 19349124 [TBL] [Abstract][Full Text] [Related]
4. [Drug therapy for osteoporosis associated with rheumatoid arthritis (vitamin D)]. Tsurukami H; Nakamura T Clin Calcium; 2001 May; 11(5):623-7. PubMed ID: 15775565 [TBL] [Abstract][Full Text] [Related]
5. Bisphosphonates: a review of their novel anti-inflammatory properties and potential for the treatment of rheumatoid arthritis. Dunn CJ; Slatter JG; Nugent RA IDrugs; 1998 Aug; 1(4):429-41. PubMed ID: 18465576 [TBL] [Abstract][Full Text] [Related]
6. Long-term effects of infliximab on bone and cartilage turnover markers in patients with rheumatoid arthritis. Chopin F; Garnero P; le Henanff A; Debiais F; Daragon A; Roux C; Sany J; Wendling D; Zarnitsky C; Ravaud P; Thomas T Ann Rheum Dis; 2008 Mar; 67(3):353-7. PubMed ID: 17644538 [TBL] [Abstract][Full Text] [Related]
7. Avascular mandibular osteonecrosis in association with bisphosphonate therapy: a report on four patients. Friedrich RE; Blake FA Anticancer Res; 2007; 27(4A):1841-5. PubMed ID: 17649782 [TBL] [Abstract][Full Text] [Related]
8. Effects of glucocorticoid treatment on focal and systemic bone loss in rheumatoid arthritis. Di Munno O; Delle Sedie A J Endocrinol Invest; 2008 Jul; 31(7 Suppl):43-7. PubMed ID: 18791351 [TBL] [Abstract][Full Text] [Related]
9. Bone metabolism changes during anti-TNF-alpha therapy in patients with active rheumatoid arthritis. Seriolo B; Paolino S; Sulli A; Ferretti V; Cutolo M Ann N Y Acad Sci; 2006 Jun; 1069():420-7. PubMed ID: 16855169 [TBL] [Abstract][Full Text] [Related]
10. Paraarticular trabecular bone loss at the ultradistal radius and increased arterial stiffening in postmenopausal patients with rheumatoid arthritis. Tanaka K; Inaba M; Goto H; Nagata-Sakurai M; Sakai S; Yamada S; Ueda M; Ishimura E; Nishizawa Y J Rheumatol; 2006 Apr; 33(4):652-8. PubMed ID: 16583470 [TBL] [Abstract][Full Text] [Related]
11. Bisphosphonates: mode of action and pharmacology. Russell RG Pediatrics; 2007 Mar; 119 Suppl 2():S150-62. PubMed ID: 17332236 [TBL] [Abstract][Full Text] [Related]
12. Bone loss in inflammatory arthritis: mechanisms and therapeutic approaches with bisphosphonates. Romas E Best Pract Res Clin Rheumatol; 2005 Dec; 19(6):1065-79. PubMed ID: 16301197 [TBL] [Abstract][Full Text] [Related]
13. Optimizing the management of postmenopausal osteoporosis with bisphosphonates: the emerging role of intermittent therapy. Miller PD Clin Ther; 2005 Apr; 27(4):361-76. PubMed ID: 15922811 [TBL] [Abstract][Full Text] [Related]
14. Clinical value of bisphosphonates in cancer therapy. Lüftner D; Henschke P; Possinger K Anticancer Res; 2007; 27(4A):1759-68. PubMed ID: 17649770 [TBL] [Abstract][Full Text] [Related]
15. Changes in hand and generalised bone mineral density in patients with recent-onset rheumatoid arthritis. Güler-Yüksel M; Allaart CF; Goekoop-Ruiterman YP; de Vries-Bouwstra JK; van Groenendael JH; Mallée C; de Bois MH; Breedveld FC; Dijkmans BA; Lems WF Ann Rheum Dis; 2009 Mar; 68(3):330-6. PubMed ID: 18375540 [TBL] [Abstract][Full Text] [Related]
16. Osteoporosis in experimental postmenopausal polyarthritis: the relative contributions of estrogen deficiency and inflammation. Jochems C; Islander U; Erlandsson M; Verdrengh M; Ohlsson C; Carlsten H Arthritis Res Ther; 2005; 7(4):R837-43. PubMed ID: 15987485 [TBL] [Abstract][Full Text] [Related]
17. [The successful development of bisphosphonates in the therapy of osteoporosis]. Fassbender WJ; Stumpf UC; Kurth A Med Klin (Munich); 2006 Jun; 101 Suppl 1():6-14. PubMed ID: 16826363 [TBL] [Abstract][Full Text] [Related]
18. [Application of bisphosphonates for periodontitis]. Shinoda H; Takeyama S Clin Calcium; 2006 Feb; 16(2):341- 47. PubMed ID: 16465039 [TBL] [Abstract][Full Text] [Related]
19. [Pathologic condition of osteoporosis in rheumatoid arthritis]. Suwa A; Saito E; Wakabayashi T; Suzuki Y Clin Calcium; 2007 Aug; 17(8):1262-6. PubMed ID: 17660625 [TBL] [Abstract][Full Text] [Related]
20. Changes in bone mineral density in patients with recent onset, active rheumatoid arthritis. Güler-Yüksel M; Bijsterbosch J; Goekoop-Ruiterman YP; de Vries-Bouwstra JK; Hulsmans HM; de Beus WM; Han KH; Breedveld FC; Dijkmans BA; Allaart CF; Lems WF Ann Rheum Dis; 2008 Jun; 67(6):823-8. PubMed ID: 17644545 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]